hn.today

New federal rule will require prescription drug middlemen to share payment data

statnews.com6 points3 comments
Screenshot of New federal rule will require prescription drug middlemen to share payment data

A finalized federal regulation will require pharmacy benefit managers (PBMs), the intermediaries that manage prescription drug benefits for employers and workers, to disclose how they are compensated. Beginning July 1, 2027, PBMs must report to the employers that hire them payments and fees from drugmakers, consulting firms, and other entities. Required disclosures include drug rebates, spread pricing - the difference between what a health plan pays a PBM and what the PBM pays a pharmacy - and financial ties to brokers and consultants that may create conflicts of interest. The change will expose payment information that has largely been closely guarded.

Federal officials estimate the rule will cover more than 70 PBMs and 130,000 employers, and produce over $800 million in annual savings through lower drug costs. The measure is presented as a way for employers to see the full range of financial incentives shaping their drug-benefit arrangements, rather than relying on incomplete information about PBM compensation. Its implementation is not immediate: disclosures start in mid-2027. PBMs and their lobbyists had previously warned they might sue over the administration’s proposal, signaling a possible legal fight over the new transparency requirements.

Read on statnews.com3 comments on Hacker News

Summary generated by AI from the linked article. hn.today is not affiliated with Hacker News or Y Combinator.

More in Other

The daily digest

Today's best Hacker News stories, summarized and screenshotted, one email a day.